The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Wed., Sep. 23, 5:48 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #28. Neogen Corporation Chem-Tech

Acquirer: Neogen Corporation (NASDAQ:NEOG)
Acquiree: Chem-Tech
Details: Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.

Neogen develops, manufactures, and markets a line of products for food and animal safety. Co.'s segments are: Food Safety, which is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation; and Animal Safety, which is engaged in the development, production and marketing of products dedicated to animal safety, including a range of consumable products marketed to veterinarians and animal health product distributors, and provides genomic identification and related interpretive bioinformatic services.

NEOG SEC Filing Email Alerts Service


Open the NEOG Page at The Online Investor »

Company Name: 
Neogen Corp
Website: 
www.neogen.com
Sector: 
Diagnostics
Number of ETFs Holding NEOG: 
54
Total Market Value Held by ETFs: 
$901.15M
Total Market Capitalization: 
$4.00B
% of Market Cap. Held by ETFs: 
22.56%
 

Open the NEOG Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (2.67 out of 4)
21st percentile
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 28 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.